ログイン

Module 2 (Part 6)
68問 • 1年前
  • ユーザ名非公開
  • 通報

    問題一覧

  • 1

    CO-ENZYME in TRANSAMINATION

    Pyridoxal Phosphate

  • 2

    Vitamin precurson fot Pyridoxal Phosphate

    Vit B6

  • 3

    Prsosthetic group of Cytochrome oxidasw

    Copper

  • 4

    Tightly bound

    Co-enzymes

  • 5

    Derived from vitamins

    Co-factors

  • 6

    Enzyme can cause kinetic rate enhancement if a reaction and explains how reaction rates depend on the CONCENTRATION of enzymes and substrates

    Michaelis Menten

  • 7

    The x-axis is the RECIPROCAL of the substrate concentration, or 1 / [S], and the y-axis is the reciprocal of the reaction velocity

    Lineweaver Burk

  • 8

    Demonstrates enzyme COOPERATIVITY. The binding of a substrate to one active site in a molecule increases the likelihood that the substrate will bind to the other active sites

    Sigmoidal Curve

  • 9

    Nucleoside analogs can be use as

    Anti-Cancer, Anti-Viral

  • 10

    Nitrogen base + Ribose

    Nucleoside

  • 11

    Nitrogen base + Ribose + Phosphate Group

    Nucleotide

  • 12

    Guanosine

    Nucleoside

  • 13

    Guanosine monophosphate

    Nucleotide

  • 14

    Adenosine

    Nucleoside

  • 15

    Adenosine monophosphate

    Nucleotide

  • 16

    Guanine

    Nucleobase

  • 17

    AMP

    Nucleotide

  • 18

    ATP

    Nucleotide

  • 19

    Thymine

    Nucleobase

  • 20

    A = T

    2 Hydrogen Bonds Stabilization

  • 21

    C = G

    3 Hydrogen Bonds Stabilization

  • 22

    Template for transcribing the complementary DNA message

    mRNA

  • 23

    carry an amino acid to the ribosomes

    tRNA

  • 24

    Component of ribosomes

    rRNA

  • 25

    DNA directed DNA synthesis

    Replication

  • 26

    DNA directed RNA synthesis

    Transcription

  • 27

    RNA directed protein synthesis

    Translation

  • 28

    Site of DNA Replication

    Nucleus

  • 29

    Site of Translation

    Ribosomes

  • 30

    Site of Transcription

    Nucleus

  • 31

    Opens/unwinds/unzips/seperate the DNA strand

    Helicase

  • 32

    Anneals a primer

    Primase

  • 33

    Elongates the DNA by adding complementary bases to the strand

    DNA Polymerase

  • 34

    Joins discontinuous strands

    DNA Ligase

  • 35

    Untangles the DNA by removing supercoils

    Topoisomerase

  • 36

    a CONTINOUS single DNA strand that, during DNA replication, is replicated inthe 3' – 5' direction

    Leading Strand

  • 37

    a DISCONTINUOUS , single DNA strand that, during DNA replication, is replicated in the 5' - 3' direction

    Lagging Strand

  • 38

    short sequences of DNA nucleotides synthesized discontinuously and later linked together by the enzyme DNA ligase to create the laggingstrand

    Okazaki Fragments

  • 39

    the end of a chromosome made of repetitive sequences of non-coding DNA that protect the chromosome from

    Telomeres

  • 40

    A change that DOES NOT AFFECT the sequence of amino acids

    Silence

  • 41

    a change to a different amino acid

    Missense

  • 42

    a change to a termination codon

    Nonsense

  • 43

    AAU to AAC

    Transitional

  • 44

    GAU to GAC

    Transitional

  • 45

    GCG to GAC

    Transversional

  • 46

    UUA to UGA

    Transversional

  • 47

    CAU to CAA

    Transversional

  • 48

    AAU (Asn) to AUC (lle)

    Missense

  • 49

    GAU (Asp) to GAC (Asp)

    Silent

  • 50

    GCC (Ala) to GAG (Glu)

    Missense

  • 51

    UUA(Leu) to UGA (Stop)

    Nonsense

  • 52

    CAU (His) to CAC (His)

    Silent

  • 53

    genetic mutation caused by a deletion or insertion in a DNA sequence that shifts the way the sequence is read.

    FRAMESHIFT MUTATION

  • 54

    Involves the removal of one or more nucleotides from a segment of DNA

    FRAMESHIFT DELETION

  • 55

    Involves the insertion of one or more nucleotides from a segment of DNA

    FRAMESHIFT INSERTION

  • 56

    Deficiency of HGPRT or Hypoxanthine Guanosine Phosphoribosyl Transferase Result: accumulation of uric acid in body fluids, self-mutilation behaviors and mental retardation

    Lesch Nyhan Syndrome

  • 57

    absence of ADENOSINE DEAMINASE

    SCID or Severe Combined Immunodeficiency

  • 58

    Not a genetic disorder, this is a deficiency in FOLATE derivatives during pregnancy

    Neural Tube Defects

  • 59

    Excessive accumulation of urate in joints

    Gout

  • 60

    Animals used for Digoxin tet

    Pigeons

  • 61

    Animals used for Tubocurarine test or Head drop test

    Rabbits

  • 62

    Animals used for Insulin testing

    Rabbits

  • 63

    Animals used for Glucagon testing

    Cat

  • 64

    use of sense organs, the macroscopic appearance of the drug its odor and taste, the sound or “snap” of the fracture, and the feel of the drug to the touch.

    Organoleptic Evaluation

  • 65

    applies physical contact to the active constituents of drugs.

    Physical Evaluation

  • 66

    Employed for powdered samples

    Microscopic Evaluation

  • 67

    Aka Bioassay Employs animals to evaluate the effects of drugs

    Pharmacologic Evaluation

  • 68

    Use of reagents. Preferred method of determining official potency

    Chemical Evalluation

  • Module 2 Part 1

    Module 2 Part 1

    ユーザ名非公開 · 100問 · 1年前

    Module 2 Part 1

    Module 2 Part 1

    100問 • 1年前
    ユーザ名非公開

    Module 1

    Module 1

    ユーザ名非公開 · 13問 · 1年前

    Module 1

    Module 1

    13問 • 1年前
    ユーザ名非公開

    Module 2

    Module 2

    ユーザ名非公開 · 100問 · 1年前

    Module 2

    Module 2

    100問 • 1年前
    ユーザ名非公開

    Antibiotics

    Antibiotics

    ユーザ名非公開 · 10問 · 1年前

    Antibiotics

    Antibiotics

    10問 • 1年前
    ユーザ名非公開

    Module 2 Part 2

    Module 2 Part 2

    ユーザ名非公開 · 100問 · 1年前

    Module 2 Part 2

    Module 2 Part 2

    100問 • 1年前
    ユーザ名非公開

    Module 2 (Part 2)

    Module 2 (Part 2)

    ユーザ名非公開 · 100問 · 1年前

    Module 2 (Part 2)

    Module 2 (Part 2)

    100問 • 1年前
    ユーザ名非公開

    Module 2 Part 3

    Module 2 Part 3

    ユーザ名非公開 · 85問 · 1年前

    Module 2 Part 3

    Module 2 Part 3

    85問 • 1年前
    ユーザ名非公開

    Module 4

    Module 4

    ユーザ名非公開 · 100問 · 1年前

    Module 4

    Module 4

    100問 • 1年前
    ユーザ名非公開

    Module 4 Part 2

    Module 4 Part 2

    ユーザ名非公開 · 100問 · 1年前

    Module 4 Part 2

    Module 4 Part 2

    100問 • 1年前
    ユーザ名非公開

    Module 4 Part 3

    Module 4 Part 3

    ユーザ名非公開 · 60問 · 1年前

    Module 4 Part 3

    Module 4 Part 3

    60問 • 1年前
    ユーザ名非公開

    Module 2 (Part 4)

    Module 2 (Part 4)

    ユーザ名非公開 · 68問 · 1年前

    Module 2 (Part 4)

    Module 2 (Part 4)

    68問 • 1年前
    ユーザ名非公開

    Randome Questions

    Randome Questions

    ユーザ名非公開 · 13問 · 1年前

    Randome Questions

    Randome Questions

    13問 • 1年前
    ユーザ名非公開

    1

    1

    ユーザ名非公開 · 100問 · 1年前

    1

    1

    100問 • 1年前
    ユーザ名非公開

    Module 2 (Part 5)

    Module 2 (Part 5)

    ユーザ名非公開 · 100問 · 1年前

    Module 2 (Part 5)

    Module 2 (Part 5)

    100問 • 1年前
    ユーザ名非公開

    2

    2

    ユーザ名非公開 · 100問 · 1年前

    2

    2

    100問 • 1年前
    ユーザ名非公開

    Module 4 Part 1

    Module 4 Part 1

    ユーザ名非公開 · 5問 · 1年前

    Module 4 Part 1

    Module 4 Part 1

    5問 • 1年前
    ユーザ名非公開

    問題一覧

  • 1

    CO-ENZYME in TRANSAMINATION

    Pyridoxal Phosphate

  • 2

    Vitamin precurson fot Pyridoxal Phosphate

    Vit B6

  • 3

    Prsosthetic group of Cytochrome oxidasw

    Copper

  • 4

    Tightly bound

    Co-enzymes

  • 5

    Derived from vitamins

    Co-factors

  • 6

    Enzyme can cause kinetic rate enhancement if a reaction and explains how reaction rates depend on the CONCENTRATION of enzymes and substrates

    Michaelis Menten

  • 7

    The x-axis is the RECIPROCAL of the substrate concentration, or 1 / [S], and the y-axis is the reciprocal of the reaction velocity

    Lineweaver Burk

  • 8

    Demonstrates enzyme COOPERATIVITY. The binding of a substrate to one active site in a molecule increases the likelihood that the substrate will bind to the other active sites

    Sigmoidal Curve

  • 9

    Nucleoside analogs can be use as

    Anti-Cancer, Anti-Viral

  • 10

    Nitrogen base + Ribose

    Nucleoside

  • 11

    Nitrogen base + Ribose + Phosphate Group

    Nucleotide

  • 12

    Guanosine

    Nucleoside

  • 13

    Guanosine monophosphate

    Nucleotide

  • 14

    Adenosine

    Nucleoside

  • 15

    Adenosine monophosphate

    Nucleotide

  • 16

    Guanine

    Nucleobase

  • 17

    AMP

    Nucleotide

  • 18

    ATP

    Nucleotide

  • 19

    Thymine

    Nucleobase

  • 20

    A = T

    2 Hydrogen Bonds Stabilization

  • 21

    C = G

    3 Hydrogen Bonds Stabilization

  • 22

    Template for transcribing the complementary DNA message

    mRNA

  • 23

    carry an amino acid to the ribosomes

    tRNA

  • 24

    Component of ribosomes

    rRNA

  • 25

    DNA directed DNA synthesis

    Replication

  • 26

    DNA directed RNA synthesis

    Transcription

  • 27

    RNA directed protein synthesis

    Translation

  • 28

    Site of DNA Replication

    Nucleus

  • 29

    Site of Translation

    Ribosomes

  • 30

    Site of Transcription

    Nucleus

  • 31

    Opens/unwinds/unzips/seperate the DNA strand

    Helicase

  • 32

    Anneals a primer

    Primase

  • 33

    Elongates the DNA by adding complementary bases to the strand

    DNA Polymerase

  • 34

    Joins discontinuous strands

    DNA Ligase

  • 35

    Untangles the DNA by removing supercoils

    Topoisomerase

  • 36

    a CONTINOUS single DNA strand that, during DNA replication, is replicated inthe 3' – 5' direction

    Leading Strand

  • 37

    a DISCONTINUOUS , single DNA strand that, during DNA replication, is replicated in the 5' - 3' direction

    Lagging Strand

  • 38

    short sequences of DNA nucleotides synthesized discontinuously and later linked together by the enzyme DNA ligase to create the laggingstrand

    Okazaki Fragments

  • 39

    the end of a chromosome made of repetitive sequences of non-coding DNA that protect the chromosome from

    Telomeres

  • 40

    A change that DOES NOT AFFECT the sequence of amino acids

    Silence

  • 41

    a change to a different amino acid

    Missense

  • 42

    a change to a termination codon

    Nonsense

  • 43

    AAU to AAC

    Transitional

  • 44

    GAU to GAC

    Transitional

  • 45

    GCG to GAC

    Transversional

  • 46

    UUA to UGA

    Transversional

  • 47

    CAU to CAA

    Transversional

  • 48

    AAU (Asn) to AUC (lle)

    Missense

  • 49

    GAU (Asp) to GAC (Asp)

    Silent

  • 50

    GCC (Ala) to GAG (Glu)

    Missense

  • 51

    UUA(Leu) to UGA (Stop)

    Nonsense

  • 52

    CAU (His) to CAC (His)

    Silent

  • 53

    genetic mutation caused by a deletion or insertion in a DNA sequence that shifts the way the sequence is read.

    FRAMESHIFT MUTATION

  • 54

    Involves the removal of one or more nucleotides from a segment of DNA

    FRAMESHIFT DELETION

  • 55

    Involves the insertion of one or more nucleotides from a segment of DNA

    FRAMESHIFT INSERTION

  • 56

    Deficiency of HGPRT or Hypoxanthine Guanosine Phosphoribosyl Transferase Result: accumulation of uric acid in body fluids, self-mutilation behaviors and mental retardation

    Lesch Nyhan Syndrome

  • 57

    absence of ADENOSINE DEAMINASE

    SCID or Severe Combined Immunodeficiency

  • 58

    Not a genetic disorder, this is a deficiency in FOLATE derivatives during pregnancy

    Neural Tube Defects

  • 59

    Excessive accumulation of urate in joints

    Gout

  • 60

    Animals used for Digoxin tet

    Pigeons

  • 61

    Animals used for Tubocurarine test or Head drop test

    Rabbits

  • 62

    Animals used for Insulin testing

    Rabbits

  • 63

    Animals used for Glucagon testing

    Cat

  • 64

    use of sense organs, the macroscopic appearance of the drug its odor and taste, the sound or “snap” of the fracture, and the feel of the drug to the touch.

    Organoleptic Evaluation

  • 65

    applies physical contact to the active constituents of drugs.

    Physical Evaluation

  • 66

    Employed for powdered samples

    Microscopic Evaluation

  • 67

    Aka Bioassay Employs animals to evaluate the effects of drugs

    Pharmacologic Evaluation

  • 68

    Use of reagents. Preferred method of determining official potency

    Chemical Evalluation